1Abstract: In addition, other mutations in the
reverse-transcriptase ""B domain"" involving either a
phenylalanine (F)-to-leucine (L) at amino acid 501 (
F501L) or an
L-to-M substitution at amino acid 515 (
L515M) have been observed during 3TC and Famciclovir therapy as well."
Abstract: Double mutants with the
L515M substitution showed intermediate defect between the YI/VDD or
F501L and the
L515M single-mutant strains.
Abstract: In both
HCC and HEK 293 cells, the mutant viruses carrying the
F501L substitution showed a decreased pregenomic RNA encapsidation level, suggesting that the defect in HBV DNA synthesis occ